Salvador, Oscar B.
HRN: 21-91-16 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/09/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/09/2022
09/17/2022
IVT
750 Mg
Q8H
Amoebic Abscess
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes